ClinicalTrials.gov
public full text
Public Domain
HER2 Expression Detection in Breast Cancer Using 99mTc-NM-02
A 99mTc-labeled anti-HER2-sdAb (99mTc-NM-02) will be developed for SPECT/CT assessment of HER2 expression in breast cancer patients. Its safety, radiation dosimetry and biodistribution, and the relationship between tumor uptake and HER2 immunohistochemistry results will be investigated.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Breast Cancer Tumor Heterogeneity#966635
- Table 1_Automatic grading of HER2 immunohistochemical whole-slide images based on a multi-scale hierarchical graph neural network.docx#1120089
- 99mTc Labelled Affibody SPECT/CT Imaging for Breast Cancer HER2 Characterization#885680
- Identification of Sentinel Lymph Nodes Using Indocyanine Green in Breast Cancer Patients#847533
- AI-based pCR Assessment/Prediction in HER2-Positive BC Using PET/MRI#1010057
Record · ID 861545
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive